Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

686 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rivaroxaban Treatment for Patients With Unprovoked or Provoked Venous Thromboembolism　- Subanalysis of the J'xactly Study.
Hisatake S, Ikeda T, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Mo M, Yamazaki T, Okumura Y, Hirayama A; J’xactly Investigators. Hisatake S, et al. Among authors: fukuda i. Circ Rep. 2022 Sep 13;4(10):490-498. doi: 10.1253/circrep.CR-22-0082. eCollection 2022 Oct 7. Circ Rep. 2022. PMID: 36304427 Free PMC article.
Effectiveness and safety of rivaroxaban in patients with venous thromboembolism and active cancer: A subanalysis of the J'xactly study.
Hisatake S, Ikeda T, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Mo M, Yamazaki T, Okumura Y, Hirayama A; J'xactly Investigators. Hisatake S, et al. Among authors: fukuda i. J Cardiol. 2023 Mar;81(3):268-275. doi: 10.1016/j.jjcc.2022.11.007. Epub 2022 Nov 15. J Cardiol. 2023. PMID: 36400414 Free article.
Effectiveness and safety of the direct oral anticoagulant in acute distal deep vein thrombosis: From the prospective multicenter observational study, J'xactly, in Japan.
Mo M, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Ikeda T, Yamazaki T, Okumura Y, Hirayama A; J’xactly Investigators. Mo M, et al. Among authors: fukuda i. Phlebology. 2023 Feb;38(1):4-15. doi: 10.1177/02683555221141310. Epub 2022 Nov 26. Phlebology. 2023. PMID: 36433754
Relationship between baseline D-dimer and prognosis in Japanese patients with venous thromboembolism: Insights from the J'xactly study.
Migita S, Okumura Y, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Ikeda T, Mo M, Yamazaki T, Hirayama A. Migita S, et al. Among authors: fukuda i. Front Cardiovasc Med. 2023 Feb 9;10:1074661. doi: 10.3389/fcvm.2023.1074661. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36844735 Free PMC article.
Duration of Initial Intensive Rivaroxaban Therapy for Patients With Venous Thromboembolism　- Subanalysis of the J'xactly Study.
Nakamura M, Fukuda I, Yamada N, Takayama M, Maeda H, Yamashita T, Ikeda T, Mo M, Yamazaki T, Okumura Y, Hirayama A; J’xactly Investigators. Nakamura M, et al. Among authors: fukuda i. Circ Rep. 2023 Mar 24;5(4):144-151. doi: 10.1253/circrep.CR-23-0008. eCollection 2023 Apr 10. Circ Rep. 2023. PMID: 37025939 Free PMC article.
Long-Term Follow-up Study of Hospitalizations for Acute Coronary Syndrome in Kobe-City and Other Districts Under the Hyogo Smoking Ban Legislation　- A Nationwide Database Study.
Nakai M, Iwanaga Y, Sumita Y, Amano T, Fukuda I, Hirano T, Iida M, Katanoda K, Miyamoto Y, Nakamura M, Saku K, Tabuchi T, Yamato H, Zhang B, Fujiwara H. Nakai M, et al. Among authors: fukuda i. Circ J. 2023 Oct 25;87(11):1680-1685. doi: 10.1253/circj.CJ-23-0191. Epub 2023 Aug 22. Circ J. 2023. PMID: 37612072 Free article.
686 results